Bronchopulmonary dysplasia (BPD) is an important morbidity in preterm infants that has short- and long-term serious adverse consequences for infants, their families, and the health care system.
1-3 Approximately 45% of preterm infants born at less than 29 weeks’ gestation are diagnosed as having BPD.
4 While accurate and timely diagnosis of the condition is important to identify high-risk infants in need of surveillance or special support, prevalence of BPD has also been proven to be a valuable short-term indicator for benchmarking the quality of neonatal care provided by institutions, networks, and countries.
4